The University of Chicago Header Logo

Connection

Richard Schilsky to Sulfonamides

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Sulfonamides.
Richard Schilsky
Connection Strength
0.186
Sulfonamides
  1. Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO Precis Oncol. 2022 Nov; 6:e2200191.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.